Cardiac Failure Completed Phase 2 Trials for Cimlanod (DB14983)

Also known as: Failure; Cardiac / Heart failure / Heart failure (disorder) / Failure heart / Heart failure (NOS) / Heart failures / Heart: [weak] or [failure NOS] / Heart failure NOS (disorder) / Heart failure NOS / (Congestive cardiac failure) or (dropsy) or (cardiac insufficiency) or (right heart failure) or (right ventricular failure) / Heart failure, unspecified / Cardiac failure NOS / Cardiac failure (NOS) / Cardiac insufficiency / Insufficiency cardiac / Cardiac function failure / Cardiac function failed / Heart insufficiency

IndicationStatusPhase
DBCOND0040020 (Cardiac Failure)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03730961An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticTreatment
NCT03357731A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic FunctionTreatment